Insulet | PODD - Gross Profit On Sales

Stock Price
349.75
Daily Change
1.32 0.38%
Monthly
14.73%
Yearly
59.61%
Q3 Forecast
345.54

Insulet reported $452.2M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.




Gross Profit On Sales Change Date
Abbott USD 5.87B 50M Jun/2025
Align Technology USD 708.12M 28.01M Jun/2025
AtriCure USD 101.48M 8.85M Jun/2025
Avanos Medical USD 92.1M 2.3M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Boston Scientific USD 3.42B 228M Jun/2025
Cardinal Health USD 2.11B 10M Jun/2025
Cooper Companies USD 692M 12.9M Jul/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Globus Medical USD 1.21B 809.01M Jun/2025
ICU Medical USD 208.06M 2.04M Jun/2025
Insulet USD 452.2M 43.2M Jun/2025
Integra LifeSciences USD 209.33M 5.81M Jun/2025
J&J USD 14.6B 816M Mar/2025
Masimo USD 233.3M 700K Jun/2025
Medtronic USD 5.12B 695M Jul/2025
Merit Medical Systems USD 184.49M 12.47M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Solventum Corp USD 1.18B 51M Jun/2025
Stryker USD 3.84B 30M Jun/2025
Tandem Diabetes Care USD 125.85M 7.45M Jun/2025
Teleflex USD 431.08M 41.65M Jun/2025
West Pharmaceutical Services USD 273.9M 42M Jun/2025
Zimmer Biomet Holdings USD 1.32B 34.8M Jun/2025